Mariner Investment Group »

Esperion Therapeutics shares owned by Mariner Investment Group

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Mariner Investment Group from 13F filings

Historical chart of Mariner Investment Group investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Mariner Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Mariner Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $510k 400k 1.28

More positions owned by Mariner Investment Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Marathon Digital Holdings In Call Option (MARA)
Spdr Ser Tr S&p Regl Bkg (KRE)
Diebold Nixdorf Com Shs (DBD)
Eaton Vance Municipal Bond Fund (EIM)
BlackRock Municipal Income Trust II (BLE)
Blackrock Muniyield Fund (MYD)
Esperion Therapeutics Call Option (ESPR)
Eaton Vance Muni Income Trus Sh Ben Int (EVN)
Nuveen Muni Value Fund (NUV)
Terawulf Call Option (WULF)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Etf Ser Solutions Us Glb Jets Put Option (JETS)

View all positions for Mariner Investment Group

Top funds holding Esperion Therapeutics

Daniel D. Thurber
Vanguard Group
Bellevue Group
Meditor
Millennium Management
Two Sigma Investments
Two Sigma Advisers
Jpmorgan Chase & Co
Tang Capital Management
D. E. Shaw & Co
Walleye Trading
GSA Capital Partners
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Goldman Sachs Group

View all funds holding Esperion Therapeutics